Patent details

EP1294879 Title: THYMIC STROMAL LYMPHOPOIETIN RECEPTOR MOLECULES AND USES THEREOF

Basic Information

Publication number:
EP1294879
PCT Application Number:
PCT/US/2001/020820
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019488378
PCT Publication Number:
WO/2002/000724
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
THYMIC STROMAL LYMPHOPOIETIN RECEPTOR MOLECULES AND USES THEREOF
French Title of Invention:
MOLECULES DE RECEPTEUR DE LYMPHOPOIETINE DE STROMA THYMIQUE ET UTILISATIONS DE CELLES-CI
German Title of Invention:
THYMUS-STROMA LYMPHOPOIETIN REZEPTOR-MOLEKÜLE UND DEREN VERWENDUNG
SPC Number:

Dates

Filing date:
28/06/2001
Grant date:
31/12/2008
EP Publication Date:
31/12/2008
PCT Publication Date:
03/01/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/03/2003
EP B1 Publication Date:
31/12/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
28/06/2009
Expiration date:
28/06/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/06/2001
 
 

Name:
AMGEN INC.
Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Inventor

1

Name:
CHANG Ming-Shi
Address:
Taiwan (TW)

2

Name:
SARIS Christiaan, M.
Address:
United States (US)

Priority

Priority Number:
214866 P
Priority Date:
28/06/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
C12N 15/12;
Filing date Document type Number of pages